Memantine Hydrochloride Tablet, Film Coated
Product Images NDC 70771-1119

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 70771-1119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine Hydrochloride Tablets (Dd8e677c B9da 439e Bdaf 36dfaa3b5b07 10)

This is a pharmaceutical label for Memantine Hydrochloride e.c, a drug used to treat Alzheimer's disease. The label includes information on dosage and storage, as well as a warning to keep the drug out of reach of children. The drug is manufactured by Cadila Healthcare Ltd, located in Ahmedabad, India. The label also instructs the pharmacist to dispense patient information to each patient.*

FDA Label Image

Memantine Hydrochloride Tablets (Dd8e677c B9da 439e Bdaf 36dfaa3b5b07 11)

This is a label for Memantine Hydrochloride tablets USP, which should be dispensed by pharmacists with accompanying patient information. The tablets are manufactured by Cadila Healthcare L. in Ahmedabad, India and come in a tight container. The label lists the drug's name, dosage, and storage requirements. There is a warning to keep the medication away from children. The label also includes a code for the drug's National Drug Code, as well as a size of 100 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.